1. Critical Decision Points in Insomnia

2. Differences in Mechanisms of Action Among Insomnia Drug Classes

3. Non-GABA Receptor Targeted Agents

4. Switching to Non-GABA Receptor Targeted Therapy

5. Consideration of Sleep and Medical History

6. Dosing and Titrating Treatment

7. Transitioning From a BZD or Non-BZD to a Non-GABA Receptor Targeted Agent

8. Managing Patient Expectations

9. Key Educational Points When Starting Non-GABA Receptor Targeted Agents

10. Following Up and Addressing Other Issues Patients May Have During the Transition

11. Concluding Remarks

12. Abbreviations